Hereditary insensitivity to pain with anhidrosis: genes and variants
Explore variant evidence for Hereditary insensitivity to pain with anhidrosis across 1 analyzed protein (NTRK1). Linked ClinVar records include 34 pathogenic or likely pathogenic variants, 305 variants of uncertain significance and 57 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hereditary insensitivity to pain with anhidrosis
NTRK1: High affinity nerve growth factor receptor
Nerve-growth-factor signaling through this pathway supports survival and differentiation of sensory and sympathetic neurons. Loss-of-function variants cause congenital insensitivity to pain with anhidrosis, whereas oncogenic NTRK1 fusions can drive diverse cancers.
34 ClinVar pathogenic / likely pathogenic and 362 uncertain variants in NTRK1 have source records linked to Hereditary insensitivity to pain with anhidrosis. Association strength is not clinical gene validity.
Where Hereditary insensitivity to pain with anhidrosis variants cluster
- NTRK1 Protein kinase (positions 510–781): 25 of 32 ClinVar pathogenic / likely pathogenic variants, 2.3× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Hereditary insensitivity to pain with anhidrosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NTRK1 G577S | 577 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R654C | 654 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R771H | 771 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R771C | 771 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 G577R | 577 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| NTRK1 G517E | 517 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 P695L | 695 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 G714S | 714 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 G724S | 724 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 P768L | 768 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R602Q | 602 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R649W | 649 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 D674Y | 674 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R692H | 692 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 L700P | 700 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 V211E | 211 | Ig-like C2-type 1 | Pathogenic / likely pathogenic (★★) |
| NTRK1 L213P | 213 | Ig-like C2-type 1 | Pathogenic / likely pathogenic (★★) |
| NTRK1 R686H | 686 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NTRK1 R654P | 654 | Protein kinase | Pathogenic / likely pathogenic (★) |
| NTRK1 R654H | 654 | Protein kinase | Pathogenic / likely pathogenic (★) |
| NTRK1 M1K | 1 | Pathogenic / likely pathogenic (★) | |
| NTRK1 M1L | 1 | Pathogenic / likely pathogenic (★) | |
| NTRK1 S698N | 698 | Protein kinase | Pathogenic / likely pathogenic (★) |
| NTRK1 V715L | 715 | Protein kinase | Pathogenic / likely pathogenic (★) |
| NTRK1 R347P | 347 | Ig-like C2-type 2 | Pathogenic / likely pathogenic (★) |
| NTRK1 M587V | 587 | Protein kinase | Pathogenic / likely pathogenic (★) |
| NTRK1 E590K | 590 | Protein kinase | Pathogenic / likely pathogenic (★) |
| NTRK1 G577V | 577 | Protein kinase | Pathogenic / likely pathogenic |
| NTRK1 H604Y | 604 | Protein kinase | Pathogenic / likely pathogenic |
| NTRK1 R744P | 744 | Protein kinase | Pathogenic / likely pathogenic |
| NTRK1 R85S | 85 | Extracellular | Pathogenic / likely pathogenic |
| NTRK1 G613V | 613 | Protein kinase | Pathogenic / likely pathogenic |
| NTRK1 R780P | 780 | Protein kinase | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Hereditary insensitivity to pain with anhidrosis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| NTRK1 R692C | 692 | Protein kinase | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R692H at the same position is pathogenic; REVEL 0.907 |
| NTRK1 V715M | 715 | Protein kinase | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; V715L at the same position is pathogenic; REVEL 0.907 |
| NTRK1 V715A | 715 | Protein kinase | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; V715L at the same position is pathogenic; REVEL 0.946 |
Which prediction tools work for Hereditary insensitivity to pain with anhidrosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 92 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 87 out of 100
- SIFT: 84 out of 100
- phyloP: 64 out of 100
- SpliceAI: 58 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Hereditary insensitivity to pain with anhidrosis
- Charcot-Marie-Tooth disease, also linked to NTRK1
- Ovarian cancer, also linked to NTRK1
- Colorectal cancer, also linked to NTRK1
- Non-small cell lung carcinoma, also linked to NTRK1
- Familial medullary thyroid carcinoma, also linked to NTRK1
Frequently asked questions
Which genes have records linked to Hereditary insensitivity to pain with anhidrosis?
This view contains 1 analyzed proteins: NTRK1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 34 pathogenic or likely pathogenic variants, 305 variants of uncertain significance and 57 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 415 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center